MCID: MYM001
MIFTS: 56

Myoma

Categories: Cancer diseases, Muscle diseases, Reproductive diseases

Aliases & Classifications for Myoma

MalaCards integrated aliases for Myoma:

Name: Myoma 12 56 45 15 74
Neoplasms, Muscle Tissue 45 74
Muscle Benign Neoplasm 12 15
Myomatous Neoplasm 12 74
Benign Neoplasm of the Muscle 12
Muscle Tissue Neoplasm 12
Neoplasm of Muscle 12
Muscle Neoplasms 56
Muscle Neoplasm 12
Myomatous Tumor 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2691 DOID:461
NCIt 51 C4063 C4882
SNOMED-CT 69 66357004 92237006
ICD10 34 D21

Summaries for Myoma

Disease Ontology : 12 A muscle benign neoplasm that is characterized as benign hyperplastic lesions of uterine smooth muscle cells.

MalaCards based summary : Myoma, also known as neoplasms, muscle tissue, is related to intravenous leiomyomatosis and leiomyomatosis, and has symptoms including muscle weakness, myoclonus and myalgia. An important gene associated with Myoma is PGR (Progesterone Receptor), and among its related pathways/superpathways is Aromatase Inhibitor Pathway (Breast Cell), Pharmacodynamics. The drugs Leuprolide and Hyaluronic acid have been mentioned in the context of this disorder. Affiliated tissues include uterus, bone and smooth muscle, and related phenotypes are cellular and homeostasis/metabolism

Wikipedia : 77 Myoma is a kind of mesenchymal... more...

Related Diseases for Myoma

Diseases related to Myoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 178)
# Related Disease Score Top Affiliating Genes
1 intravenous leiomyomatosis 30.7 DES ESR1
2 leiomyomatosis 30.5 ESR1 GNRH1 MED12 PGR
3 leiomyosarcoma 30.5 DES MED12 PGR
4 pleomorphic lipoma 30.4 HMGA2 PGR
5 leiomyoma, uterine 30.3 ESR1 HMGA2 PGR
6 adenomyosis 30.2 CYP19A1 ESR1 GNRH1 HOXA10 PGR
7 diffuse peritoneal leiomyomatosis 30.1 ESR1 MED12 PGR
8 uterine sarcoma 30.1 CYP19A1 DES ESR1
9 adhesions of uterus 30.0 ESR1 HOXA10
10 polycystic ovary syndrome 30.0 CYP19A1 GNRH1 LEP
11 benign metastasizing leiomyoma 29.9 CYP19A1 DES PGR
12 endometrial stromal sarcoma 29.9 CYP19A1 DES ESR1 PGR
13 endometriosis 29.9 CYP19A1 ESR1 GNRH1 HOXA10 PGR
14 endometrial cancer 29.6 CYP19A1 ESR1 GNRH1 HOXA10 PGR
15 endometrial adenocarcinoma 29.6 ESR1 HOXA10 PGR
16 breast fibroadenoma 29.5 CYP19A1 ESR1 HMGA2 MED12 PGR
17 leiomyoma 29.4 CYP19A1 DES ESR1 GNRH1 HMGA2 MED12
18 skeletal muscle neoplasm 12.2
19 dartoic leiomyoma 11.3
20 carney complex variant 11.1
21 skeletal muscle cancer 11.0
22 muscle cancer 11.0
23 mixed endometrial stromal and smooth muscle tumor 11.0
24 uterus leiomyosarcoma 10.8
25 vestibular gland benign neoplasm 10.4 ESR1 PGR
26 bartholin's gland adenoma 10.4 ESR1 PGR
27 vulvar syringoma 10.4 ESR1 PGR
28 lung leiomyoma 10.4 ESR1 PGR
29 glassy cell carcinoma of the cervix 10.4 ESR1 PGR
30 vulvar benign neoplasm 10.4 ESR1 PGR
31 trigonitis 10.4 ESR1 PGR
32 vulvar leiomyoma 10.4 ESR1 PGR
33 predominantly cortical thymoma 10.4 ESR1 PGR
34 breast medullary carcinoma 10.4 ESR1 PGR
35 breast scirrhous carcinoma 10.4 ESR1 PGR
36 bartholin's gland benign neoplasm 10.4 ESR1 PGR
37 oncocytic breast carcinoma 10.4 ESR1 PGR
38 bizarre leiomyoma 10.4 MED12 PGR
39 progesterone resistance 10.4 ESR1 PGR
40 thrombosis 10.4
41 endometrial squamous cell carcinoma 10.4 ESR1 PGR
42 cribriform carcinoma 10.4 ESR1 PGR
43 endometrial mucinous adenocarcinoma 10.4 ESR1 PGR
44 adenoid basal cell carcinoma 10.4 ESR1 PGR
45 apocrine adenocarcinoma 10.4 ESR1 PGR
46 deep angioma 10.4 ESR1 PGR
47 hypertensive encephalopathy 10.4 CYP19A1 EPO
48 synchronous bilateral breast carcinoma 10.4 ESR1 PGR
49 breast adenoid cystic carcinoma 10.4 ESR1 PGR
50 female reproductive endometrioid cancer 10.3 ESR1 PGR

Graphical network of the top 20 diseases related to Myoma:



Diseases related to Myoma

Symptoms & Phenotypes for Myoma

UMLS symptoms related to Myoma:


muscle weakness, myoclonus, myalgia, torticollis, muscle cramp, muscle rigidity, muscle spasticity

MGI Mouse Phenotypes related to Myoma:

47 (show all 14)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.18 CD3E CYP19A1 DES EPO ESR1 LEP
2 homeostasis/metabolism MP:0005376 10.18 CYP19A1 DES EPO ESR1 GNRH1 HPSE2
3 endocrine/exocrine gland MP:0005379 10.15 CD3E CYP19A1 ESR1 GNRH1 HOXA10 LEP
4 cardiovascular system MP:0005385 10.14 CYP19A1 DES EPO ESR1 LEP MED12
5 integument MP:0010771 10.11 CD3E CYP19A1 EPO ESR1 GNRH1 LEP
6 mortality/aging MP:0010768 10.1 CD3E DES EPO ESR1 HPSE2 LEP
7 digestive/alimentary MP:0005381 10.05 CYP19A1 ESR1 GNRH1 HOXA10 HPSE2 LEP
8 limbs/digits/tail MP:0005371 9.91 EPO ESR1 HOXA10 LEP MED12 PGR
9 nervous system MP:0003631 9.91 CD3E CYP19A1 ESR1 GNRH1 HOXA10 LEP
10 muscle MP:0005369 9.85 CYP19A1 DES EPO ESR1 LEP PGR
11 neoplasm MP:0002006 9.8 CD3E ESR1 GNRH1 LEP PGR XRCC4
12 renal/urinary system MP:0005367 9.63 CYP19A1 ESR1 GNRH1 HPSE2 LEP OXT
13 reproductive system MP:0005389 9.56 CYP19A1 ESR1 GNRH1 HOXA10 LEP OXT
14 skeleton MP:0005390 9.28 CYP19A1 EPO ESR1 GNRH1 HOXA10 LEP

Drugs & Therapeutics for Myoma

Drugs for Myoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 453)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Leuprolide Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 53714-56-0 657181 3911
2
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1,Phase 2 9004-61-9 53477741
3
Dimenhydrinate Approved Phase 4 523-87-5 441281
4
Dienogest Approved Phase 4 65928-58-7
5
Nandrolone decanoate Approved, Illicit Phase 4 360-70-3 9677
6
Nandrolone phenpropionate Approved, Illicit, Investigational Phase 4 62-90-8 229455
7
Goserelin Approved Phase 4,Phase 3 65807-02-5 5311128 47725
8
Desogestrel Approved Phase 4 54024-22-5 40973
9
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 23214-92-8 31703
10
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
11
Morphine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 57-27-2 5288826
12
Calcium Carbonate Approved, Investigational Phase 4,Phase 3 471-34-1
13
Zinc oxide Approved Phase 4 1314-13-2
14
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 46835353 5284616 6436030
15
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
16
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 70789204 6442177
17
Anastrozole Approved, Investigational Phase 4,Phase 3 120511-73-1 2187
18
Letrozole Approved, Investigational Phase 4,Phase 2,Phase 1 112809-51-5 3902
19
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Not Applicable 137-58-6 3676
20
Dinoprostone Approved Phase 4,Not Applicable 363-24-6 5280360
21
Misoprostol Approved Phase 4,Phase 3,Phase 2 59122-46-2 5282381
22
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
23
Zinc Approved, Investigational Phase 4 7440-66-6 32051
24
leucovorin Approved Phase 4,Phase 2 58-05-9 143 6006
25
Ferrous fumarate Approved Phase 4 141-01-5
26
Hydroxocobalamin Approved Phase 4 13422-51-0 15589840 11953898
27
Nicotinamide Approved, Investigational Phase 4,Phase 2 98-92-0 936
28
Methylcobalamin Approved, Experimental, Investigational Phase 4 13422-55-4
29
Tocopherol Approved, Investigational Phase 4 1406-66-2 14986
30
Cetrorelix Approved, Investigational Phase 4 120287-85-6 25074887 16129715
31
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
32
Acetaminophen Approved Phase 4,Phase 1 103-90-2 1983
33
Ibuprofen Approved Phase 4,Not Applicable 15687-27-1 3672
34
Ethanol Approved Phase 4,Not Applicable 64-17-5 702
35
Mifepristone Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 84371-65-3 55245
36
Levonorgestrel Approved, Investigational Phase 4,Not Applicable 797-63-7, 17489-40-6 13109
37
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 57-83-0 5994
38
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 1177-87-3
39
Nitrous oxide Approved, Vet_approved Phase 4,Not Applicable 10024-97-2 948
40
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 50-02-2 5743
41
Tranexamic Acid Approved Phase 4,Phase 2,Phase 3,Not Applicable 1197-18-8 5526
42
Oxytocin Approved, Vet_approved Phase 4,Phase 2,Phase 3 50-56-6 53477758 439302
43
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
44
Pregabalin Approved, Illicit, Investigational Phase 4 148553-50-8 5486971
45
Glycine Approved, Nutraceutical, Vet_approved Phase 4,Phase 1,Not Applicable 56-40-6 750
46
Thiamine Approved, Investigational, Nutraceutical, Vet_approved Phase 4 70-16-6, 59-43-8 1130
47
Pyridoxine Approved, Investigational, Nutraceutical, Vet_approved Phase 4 65-23-6 1054
48
Vitamin C Approved, Nutraceutical Phase 4,Phase 3 50-81-7 54670067 5785
49
Vitamin E Approved, Nutraceutical, Vet_approved Phase 4 59-02-9 14985
50
Vitamin D3 Approved, Nutraceutical Phase 4,Not Applicable 67-97-0 5280795 6221

Interventional clinical trials:

(show top 50) (show all 605)
# Name Status NCT ID Phase Drugs
1 Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas Unknown status NCT02361905 Phase 4 ulipristal acetate;Leuprolide acetate
2 Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma Unknown status NCT02361879 Phase 4 ulipristal acetate;Leuprolide acetate
3 Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation Unknown status NCT02357563 Phase 4 ulipristal acetate;Leuprolide acetate
4 Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy Unknown status NCT01632202 Phase 4
5 IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure Unknown status NCT02601196 Phase 4 Ulipristal acetate
6 Endometrial Preparation Before Operative Hysteroscopy in Premenopausal Women Unknown status NCT02440750 Phase 4 Dienogest;Ulipristal acetate
7 Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin Unknown status NCT01738724 Phase 4 Dienogest;Goserelin;Desogestrel
8 High Intensity Focused Ultrasound Ablation Virus Myomectomy to Treat Uterine Fibroids Unknown status NCT01239641 Phase 4
9 EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children Unknown status NCT00339118 Phase 4 doxorubicin, cytoxan
10 Pilot of Letrozole for Uterine Myomas Completed NCT02470741 Phase 4 Letrozole
11 Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue Morcellators Completed NCT00743080 Phase 4
12 Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. Completed NCT01492179 Phase 4 Normal saline;Intravenous Lidocaine;Intra-abdominal Lidocaine
13 Single Versus Double Dose Intra-vaginal Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy Completed NCT02154932 Phase 4 2 doses 400 microgram misoprostol;single dose misoprostol
14 Vasopressin Administration During Laparoscopic Myomectomy: a Randomized Controlled Trial Completed NCT01393704 Phase 4 Vasopressin
15 Morphine vs. Oxycodone for Postoperative Pain Management Completed NCT00528177 Phase 4 Morphine and oxycodone
16 The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. Completed NCT00995878 Phase 4
17 SIGnificance of Routine Hysteroscopy Prior to a First 'in Vitro Fertilization'(IVF) Treatment Cycle Completed NCT01242852 Phase 4
18 Fibroids in Women of Reproductive Age and Women Pregnancy Completed NCT02620345 Phase 4 Dydrogesterone M ( case 1 );Dydrogesterone M ( case 2 )
19 Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization Completed NCT02293447 Phase 4 Lidocaine per-embolization;Lidocaine post-embolization
20 Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids Completed NCT00746031 Phase 4 GnRH analogue (Zoladex);GnRH antagonist-Cetrorelix
21 Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids Completed NCT00159328 Phase 4
22 Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure Completed NCT02227316 Phase 4 IV Ibuprofen;IV Acetaminophen;Intravenous placebo/Intravenous placebo
23 A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE) Completed NCT00628901 Phase 4
24 Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery Completed NCT01388907 Phase 4
25 Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis Recruiting NCT03500367 Phase 4 rapamycin
26 Combined Vaginal Misoprostol and Perivascular Vasopressin Recruiting NCT03815344 Phase 4 Standard;Standard-vaginal misoprostol
27 A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy Recruiting NCT03210324 Phase 4 Mifepristone tablets
28 Aromatase Plus GnRH Analogue Versus Ulippristal Acetate in Uterine Fibroids Recruiting NCT03421639 Phase 4 Ulipristal acetate;Aromatase inhibitor plus GnRH analog
29 Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids Recruiting NCT03317795 Phase 4 Levonorgestrel IUS;Tranexamic Acid
30 Misoprostol for Reduction of Blood Loss During Fibroid Surgery Recruiting NCT02209545 Phase 4 Misoprostol;Placebo
31 Ulipristal Use in Chinese Population Active, not recruiting NCT02825719 Phase 4 Ulipristal acetate;Ferrous sulphate;Tranexamic Acid
32 Oxytocin in MRI-HIFU Enrolling by invitation NCT03937401 Phase 4 Oxytocin
33 Peritoneal Cavity Conditioning Decreases Pain, Inflammation and Adhesions Terminated NCT01344486 Phase 4
34 Preemptive Analgesia Following Uterine Artery Embolization Terminated NCT01555073 Phase 4 pregabalin/celecoxib;pregabalin/placebo;celecoxib/placebo;Placebo group
35 Safety Trial of Magnetic Resonance (MR) Guided Focused Ultrasound Surgery (FUS) in Women With Uterine Fibroids Wishing to Pursue Pregnancy in the Future Terminated NCT00180739 Phase 4
36 Single Incision Laparoscopic Surgery (SILS) Versus Conventional Laparoscopic Hysterectomy Unknown status NCT01483417 Phase 3
37 Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy Unknown status NCT02011659 Phase 3 Ramosetron
38 Single-port Access Laparoscopic-assisted Vaginal Hysterectomy Unknown status NCT01048931 Phase 3
39 The Use of Doppler to Diagnose Myometrial Masses Unknown status NCT01833871 Phase 2, Phase 3
40 Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma Unknown status NCT00379457 Phase 3 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;ifosfamide;topotecan hydrochloride;vincristine sulfate;vinorelbine tartrate
41 Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids Unknown status NCT02189083 Phase 3 TSD
42 Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy Unknown status NCT01280045 Phase 3
43 Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma Unknown status NCT00821275 Phase 2, Phase 3
44 Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Unknown status NCT00075582 Phase 3 dactinomycin;cyclophosphamide;vincristine sulfate
45 PGL4001 Versus GnRH-agonist in Uterine Myomas Completed NCT00740831 Phase 3 PGL4001;leuprorelin
46 PGL4001 Versus Placebo in Uterine Myomas Completed NCT00755755 Phase 3 PGL4001 (ulipristal) and iron;PGL4001 matching placebo and iron;PGL4001 (ulipristal) and iron
47 Barbed Suture in Single-port Laparoscopic Myomectomy Completed NCT01984632 Phase 3
48 Vasopressin Versus Epinephrine in Myomectomy Completed NCT01861015 Phase 3 Epinephrine;Vasopressin
49 Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma Completed NCT01715597 Phase 3 ascorbic acid;Normal saline
50 PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata Completed NCT01642472 Phase 3 Ulipristal Acetate - open label

Search NIH Clinical Center for Myoma

Cochrane evidence based reviews: myoma

Genetic Tests for Myoma

Anatomical Context for Myoma

MalaCards organs/tissues related to Myoma:

42
Uterus, Bone, Smooth Muscle, T Cells, Testes, Nk Cells, Ovary

Publications for Myoma

Articles related to Myoma:

(show top 50) (show all 633)
# Title Authors Year
1
Expression of Antioxidant Enzymes in Patients with Uterine Polyp, Myoma, Hyperplasia, and Adenocarcinoma. ( 30978928 )
2019
2
Iatrogenic parasitic myoma and iatrogenic adenomyoma after laparoscopic morcellation: A mini-review. ( 31080671 )
2019
3
Unexpected coexistent endometriosis in women with symptomatic uterine leiomyomas is independently associated with infertility, nulliparity and minor myoma size. ( 31006843 )
2019
4
Identification of the molecular relationship between intravenous leiomyomatosis and uterine myoma using RNA sequencing. ( 30723247 )
2019
5
Two Modest Proposals: Thoughts from the Myoma/Leiomyosarcoma Controversies. ( 30904485 )
2019
6
Myoma in Septic Necrobiosis at 10 Days Post-Partum. ( 29102219 )
2019
7
Dehiscence of a Low Transverse Cesarean Scar by a Submucous Myoma in a Nongravid Uterus. ( 29709694 )
2019
8
Multidisciplinary Approach in Large-sized Submucosal Myoma: Hysteroscopic Myomectomy after Uterine Artery Embolization. ( 29969685 )
2019
9
Regarding "Multidisciplinary Approach in Large-Sized Submucous Myoma: Hysteroscopic Myomectomy after Uterine Artery Embolization". ( 30165186 )
2019
10
Recurrent Cerebral Infarction Due to Benign Uterine Myoma. ( 30366865 )
2019
11
Regarding "Multidisciplinary Approach in Large-sized Submucosal Myoma: Hysteroscopic Myomectomy after Uterine Artery Embolization". ( 30580101 )
2019
12
Disappearance of a myoma after pregnancy in a 38 years old patient, treated by Ulipristal Acetate without success before getting pregnant. ( 30898625 )
2019
13
More Than a Myoma: A Review of Myomatous Erythrocytosis Syndrome. ( 30904341 )
2019
14
Laparoscopic assisted robotic myomectomy of a huge myoma; Does robotic surgery change the borders in minimally invasive gynecology? ( 31088043 )
2019
15
Histiocyte-rich rhabdomyoblastic tumor: rhabdomyosarcoma, rhabdomyoma, or rhabdomyoblastic tumor of uncertain malignant potential? A histologically distinctive rhabdomyoblastic tumor in search of a place in the classification of skeletal muscle neoplasms. ( 30287926 )
2019
16
The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis. ( 29372159 )
2018
17
Incarceration of early gravid uterus with adenomyosis and myoma: report of two patients managed with uterine reduction. ( 30254999 )
2018
18
Unique Learning System for Uterine Artery Embolization for Symptomatic Myoma and Adenomyosis for Obstetrician-Gynecologists in Cooperation with Interventional Radiologists: Evaluation of UAE From the Point of View of Gynecologists Who Perform UAE. ( 28807810 )
2018
19
Acute intestinal obstruction due to extrinsic compression by previa myoma and ectopic pregnancy: a case report. ( 29335010 )
2018
20
Minimally Invasive Approaches to Myoma Management. ( 28734973 )
2018
21
A Lumbosacral Plexopathy Compressed by Huge Uterine Myoma. ( 29076826 )
2018
22
The uterine fibroid/myoma tumour: analysis of the global research architecture using density-equalizing mapping. ( 29198424 )
2018
23
Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy. ( 29227004 )
2018
24
Matrix Metalloproteinase Activity Correlates With Uterine Myoma Volume Reduction After Ulipristal Acetate Treatment. ( 29408988 )
2018
25
Transvaginal Natural Orifice Transluminal Endoscopic Surgery Myomectomy: A Novel Route for Uterine Myoma Removal. ( 29410143 )
2018
26
Morbidity, fertility and pregnancy outcomes after myoma enucleation by laparoscopy versus laparotomy. ( 29417281 )
2018
27
Multimodal imaging for diagnosis and management of parasitic peritoneal myoma with myxoid degeneration after laparoscopic-assisted myomectomy with electric power morcellation. ( 29516586 )
2018
28
Diagnosis and treatment of submucous myoma of the uterus with interventional ultrasound. ( 29616100 )
2018
29
Expression and prognostic value of lactate dehydrogenase-A and -D subunits in human uterine myoma and uterine sarcoma. ( 29620641 )
2018
30
Modern Myoma Treatment in the Last 20 Years: A Review of the Literature. ( 29789793 )
2018
31
Health Education Using Telephone and WeChat in Treatment of Symptomatic Uterine Myoma with High-Intensity Focused Ultrasound. ( 30185767 )
2018
32
Blood Serum Levels of Proinflammatory Cytokines (IL-1β, IL-6, TNFα, IL-8, IL-12p70, and IFNγ) in Patients with Uterine Myoma. ( 30225705 )
2018
33
Size, Type, and Location of Myoma as Predictors for Successful Laparoscopic Myomectomy: A Tertiary Government Hospital Experience. ( 30254939 )
2018
34
Perioperative outcomes of myomectomy for extreme myoma burden: A comparison of surgical approaches. ( 30391510 )
2018
35
Myoma Imaging by Gynecologic Surgeons Training in Intraoperative Ultrasound Technique. ( 30502500 )
2018
36
A case report of traditional Korean medicine treatments on uterine myoma with thyroid cancer. ( 30505680 )
2018
37
Paradoxical embolism caused by ovarian vein thrombosis extending to inferior vena cava in a female with uterine myoma. ( 30595774 )
2018
38
A case of secondary amenorrhea caused by uterine myoma successfully treated by a combined laparoscopic and hysteroscopic approach. ( 30254874 )
2017
39
May-Thurner syndrome caused by a huge uterine myoma. ( 29296055 )
2017
40
A Proteomic Analysis of Human Uterine Myoma. ( 27001059 )
2017
41
Laparoscopic Management of Huge Cervical Myoma. ( 27632929 )
2017
42
Laparoscopic Management of Huge Myoma Nascendi. ( 27632930 )
2017
43
Preoperative 3-dimensional Magnetic Resonance Imaging of Uterine Myoma and Endometrium Before Myomectomy. ( 27903466 )
2017
44
Rewriting the script: time to rethink the indications for myoma surgery. ( 28069179 )
2017
45
Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial. ( 28076829 )
2017
46
Pregnancy Outcomes After Direct Uterine Myoma Thermal Ablation: Review of the Literature. ( 28109894 )
2017
47
Pilot Study of the Mirabilis System Prototype for Rapid Noninvasive Uterine Myoma Treatment Using an Ultrasound-Guided Volumetric Shell Ablation Technique. ( 28109895 )
2017
48
Sacral Schwannoma Mimicking a Myoma Uterus. ( 28132872 )
2017
49
Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas. ( 28216458 )
2017
50
Increased risk of breast cancer in women with uterine myoma: a nationwide, population-based, case-control study. ( 28382798 )
2017

Variations for Myoma

Expression for Myoma

Search GEO for disease gene expression data for Myoma.

Pathways for Myoma

Pathways related to Myoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 9.23 CYP19A1 ESR1

GO Terms for Myoma

Biological processes related to Myoma according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.8 EPO GNRH1 LEP OXT
2 transcription initiation from RNA polymerase II promoter GO:0006367 9.69 ESR1 MED12 PGR
3 response to estradiol GO:0032355 9.54 ESR1 LEP OXT
4 stem cell differentiation GO:0048863 9.52 ESR1 HMGA2
5 female pregnancy GO:0007565 9.5 GNRH1 LEP OXT
6 response to electrical stimulus GO:0051602 9.48 EPO OXT
7 eating behavior GO:0042755 9.46 LEP OXT
8 androgen metabolic process GO:0008209 9.43 CYP19A1 ESR1
9 response to nutrient GO:0007584 9.43 CD3E EPO LEP
10 ovulation from ovarian follicle GO:0001542 9.16 LEP PGR
11 intracellular steroid hormone receptor signaling pathway GO:0030518 9.1 ESR1
12 response to prostaglandin E GO:0034695 8.96 GNRH1 OXT
13 uterus development GO:0060065 8.8 CYP19A1 ESR1 HOXA10

Molecular functions related to Myoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978 9.46 ESR1 HMGA2 HOXA10 PGR
2 steroid binding GO:0005496 8.96 ESR1 PGR
3 hormone activity GO:0005179 8.92 EPO GNRH1 LEP OXT

Sources for Myoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....